Bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitors
BackgroundImmune checkpoint inhibitors (ICIs) have left a deep impression in the treatment of non-small cell lung cancer (NSCLC), however, not all patients benefit from it. The purpose of this study was to investigate the prognostic value of baseline b…